How Wegovy vs Mounjaro Dosing Schedules Actually Compare
Wegovy vs Mounjaro Dosing: Key Mechanism Differences
When comparing Wegovy vs Mounjaro dosing schedules, the fundamental difference lies in their active ingredients and how they work. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, requiring a carefully structured 5-dose escalation from 0.25mg to 2.4mg over 16 weeks. Mounjaro uses tirzepatide, a dual-action medicine targeting both GIP and GLP-1 receptors, following a 6-dose progression from 2.5mg to 15mg over 20 weeks. This dual mechanism may allow for different dosing intervals and maintenance levels.
The dosing frequency remains consistent for both treatments—once weekly injections using pre-filled pens. However, the escalation timelines differ significantly in the Wegovy vs Mounjaro dosing comparison. Wegovy's approach focuses on gradual GLP-1 stimulation with 4-week intervals between increases, whilst Mounjaro's dual-receptor targeting may require different dose adjustment periods. Both medicines must be prescribed alongside a reduced-calorie diet and increased physical activity. EverydayMeds stocks both options, allowing your prescriber flexibility in choosing the most suitable treatment based on your individual clinical needs and dosing preferences.
Wegovy vs Mounjaro Dosing: Pricing and Value Comparison
Understanding the cost implications of Wegovy vs Mounjaro dosing helps plan your weight management investment effectively. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg at £209.99 per pen. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Mounjaro follows a different pricing structure reflecting its dual-mechanism approach, with costs varying across its six dose levels from 2.5mg through 15mg maintenance.
Bundle options provide convenience for both treatments when considering Wegovy vs Mounjaro dosing strategies. Our Intro Duo (0.25mg & 0.5mg Wegovy) costs £169.99, covering your first 8 weeks, whilst the Ultimate Stability Trio provides 3 months of maintenance 2.4mg supply for £649.99. Similar bundle arrangements exist for Mounjaro's dosing schedule. The key advantage lies in having both options available from one GPhC-registered pharmacy (#9012878), eliminating the need to source different treatments from multiple suppliers. Your prescriber can switch between treatments if initial dosing doesn't suit your tolerance levels.
Clinical Evidence Behind Wegovy vs Mounjaro Dosing Protocols
The clinical evidence supporting Wegovy vs Mounjaro dosing schedules comes from extensive Phase 3 trials with different study designs. Wegovy's dose escalation protocol was established through the STEP trial programme, with STEP 1 demonstrating that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The 16-week escalation to 2.4mg maintenance proved optimal for balancing efficacy with tolerability in this GLP-1 approach.
Mounjaro's dosing strategy emerged from the SURMOUNT trials, evaluating tirzepatide's dual GIP+GLP-1 mechanism across multiple dose levels up to 15mg weekly. These trials used different endpoints and patient populations compared to the STEP studies, making direct comparison inappropriate, but both established clear evidence for their respective dosing protocols. The longer escalation period for Mounjaro may reflect the complexity of targeting two hormone pathways simultaneously, requiring careful titration to optimise both effectiveness and patient tolerance.
How Wegovy's GLP-1 Mechanism Influences Dosing
Wegovy's semaglutide works as a GLP-1 receptor agonist, binding to receptors in your brain's appetite centres to promote feelings of fullness and reduce food cravings. This mechanism requires the specific 4-week dose escalation schedule to allow your body to adapt gradually to increased GLP-1 stimulation. Starting at 0.25mg helps minimise initial side effects whilst building tolerance for higher therapeutic doses. The progression through 0.5mg, 1mg, and 1.7mg over 16 weeks ensures optimal receptor engagement without overwhelming your system. The final 2.4mg maintenance dose provides sustained appetite regulation for long-term weight management when combined with lifestyle modifications.
EverydayMeds Wegovy vs Mounjaro Ordering Process
Accessing either treatment through EverydayMeds begins with our 3-minute online clinical assessment, designed to capture the medical information your prescriber needs for safe treatment selection. Whether you're considering Wegovy's 5-dose schedule or Mounjaro's 6-dose protocol, the same streamlined process applies. Your assessment undergoes prescriber review within 3 working days (or 24 hours with express service), ensuring clinical appropriateness for your chosen treatment. Once approved, your first pen ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This process applies to individual pens or bundle orders, giving you flexibility in how you start your weight management journey with either treatment option.
Storage Considerations in Wegovy vs Mounjaro Dosing
Storage requirements significantly impact practical use when comparing Wegovy vs Mounjaro dosing schedules. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability, maintaining potency for 6 weeks below 30°C once removed from the fridge. Mounjaro provides 21 days of room temperature stability, still adequate for most travel and daily use scenarios but requiring more careful planning for extended periods away from refrigeration. Both use simple injection pens—Wegovy's FlexTouch design and Mounjaro's equivalent system—making weekly administration straightforward regardless of which dosing protocol you follow. This storage advantage may influence treatment choice for frequent travellers or those with limited refrigeration access during the dose escalation period.
Personalised Dosing Strategy: Wegovy vs Mounjaro Selection
Choosing between Wegovy vs Mounjaro dosing approaches requires individual clinical assessment considering your medical history, previous weight loss attempts, and tolerance for potential side effects. Wegovy's single-target GLP-1 mechanism may suit patients seeking a well-established approach with extensive clinical data and predictable dose progression. The 16-week escalation provides clear milestones and allows for early assessment of treatment response and tolerability. Mounjaro's dual GIP+GLP-1 mechanism offers a different therapeutic approach that may appeal to patients who haven't responded optimally to GLP-1-only treatments previously.
Your prescriber can help navigate this decision based on factors beyond just dosing schedules, including your cardiovascular health, diabetes status, and weight management goals. EverydayMeds' advantage lies in supplying both treatments from our GPhC-registered pharmacy (#9012878), enabling treatment switches if initial dosing protocols don't achieve desired outcomes. Both Wegovy and Mounjaro are available through our platform—your prescriber can help determine which dosing strategy aligns best with your clinical profile and lifestyle requirements.
Making Your Wegovy vs Mounjaro Dosing Decision
Ready to start your weight management journey with expert clinical support? Both Wegovy and Mounjaro represent evidence-based approaches to weight management, each with distinct dosing protocols designed to optimise effectiveness whilst minimising side effects. EverydayMeds provides access to both treatments through our streamlined online service, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout. Our clinical team stands ready to guide you through the assessment process, whether you're drawn to Wegovy's established 5-dose protocol or interested in exploring Mounjaro's dual-action approach. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and take the first step towards effective, medically-supervised weight management with the treatment and dosing schedule that's right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
